SJH Emergency Medicine
From 1 September 2025, SJH will be moving from alteplase to tenecteplase for stroke thrombolysis. The tenecteplase doses are on the new stroke assessment forms. Do note that if tenecteplase is contraindicated, you can still consider alteplase.
The stroke team have provided the following links on the use of tenecteplase [editorial note - these are added in for information purposes, however if you are unsure on how to make this up or not had the appropriate training please seek additional help]: